Story thread · 2 reports / 2 sources
With $263M, LifeMine unearths a new drug for organ transplants
biopharmadive.com · 5d
How the coverage leans
Across 2 sources · syndicated copies counted once
Led by serial biotech entrepreneur Greg Verdine, the startup mined fungi genomes to find a safer alternative to the drugs widely used to prevent the body from rejecting transplanted organs.
First report: Greg Verdine’s LifeMine raises $263M for safer immunosuppressant — endpts.com, 5d
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.